Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India
Fig 1
Flow diagram indicating the selection of study population.
*RNTCP = Revised National Tuberculosis Programme of India; §DOT = Directly Observed Therapy.